Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
IMPAX LABORATORIES, Inc. (NQ: IPXL)
18.52 USD  -0.33 (-1.75%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 18.80
Bid (Size) 18.51 (4400)
Ask (Size) 18.52 (4500)
Prev. Close 18.85
Today's Range 18.38 - 18.91
52wk Range 14.41 - 27.25
Shares Outstanding 68,477,096
Dividend Yield N/A
Featured News
More News
U.S. stocks rally to lift Dow to new heights
March 05, 2013
U.S. stocks rise sharply Tuesday, lifting the Dow Jones Industrials Average above its all-time intraday and closing highs, ahead of a report on the U.S. services sector. Read More
category SNTS , QCOM , Fiber Optics , and 20 more.
from MarketWatch
Tuesday’s movers: Acura, Gilead, Apple
March 05, 2013
Shares of drug makers Acura Pharmaceuticals Inc. and Impax Laboratories Inc. made substantial moves on Tuesday in premarket trading while Apple Inc. trended on Twitter. Read More
category Computer Software , Biotechnology , Retail , and 20 more.
from MarketWatch

Featured News
Read More
Stock futures track global markets up; ISM ahead
March 05, 2013
category SNTS , Financial Services , DJH3 , and 17 more.
from MarketWatch
J.C. Penney, Impax shares drop after hours
March 04, 2013
category SNTS , Computer Software , Retail , and 17 more.
from MarketWatch
Healthcare Stocks, Including Thermo Fisher, Making Big Moves on November 13, 2012
November 13, 2012
from Investopedia Advisor Commentary
Endo Health Solutions Needs Some Solutions Of Its Own (ENDP, JNJ, BCR, IPXL)
November 07, 2012
from Investopedia Advisor Commentary
Healthcare Stocks, Including Taro Pharmaceutical, Making Big Moves on September 19, 2012
September 19, 2012
from Investopedia Advisor Commentary
Valeant Pharmaceuticals Int (USA) and Other Healthcare Stocks Making Big Moves
August 15, 2012
from Investopedia Advisor Commentary
More News
Read More
Filthy Pharma: Justice Department Taking "Especially Hard Look" At Manufacturing Plants
June 06, 2013
category NYSE:GSK , NYSE:AZN , NSE:RANBAXY , and 1 more.
from Forbes Real Time
Bernstein Liebhard LLP Announces An Investigation Concerning Impax Laboratories, Inc.
June 06, 2013
from PR Newswire
UPDATE 1-Endo Health to slash 15 pct jobs, looks to sell some assets
June 05, 2013
category companyNews
from Reuters: Company News
Impax cuts 110 jobs, expects to save $15 million
June 05, 2013
from FOX News
Impax cuts 110 jobs, expects to save $15 mln
June 05, 2013
category companyNews
from Reuters: Company News
Impax (IPXL) to Cut Workforce by 110 Positions
June 05, 2013
from StreetInsider.com News Articles
Impax Laboratories Announces Reduction in Workforce
June 05, 2013
from Business Wire News Releases
Bio-Wire Equity Surveillance – Closing Bell 6/3/2013
June 04, 2013
category INFI , RIGL , Bio/Wire , and 5 more.
from Bio-Wire.Com
Bio-Wire Equity Surveillance – Closing Bell 6/3/2013
June 03, 2013
category INFI , TSRO , Bio/Wire , and 5 more.
from Bio-Wire.Com
Impax Laboratories to Present at the Jefferies Global Healthcare Conference
June 03, 2013
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The Future of Android Looks More Like Apple Inc.
Mike Schuster
2
Boeing to Airbus: Game On
Nick Shchetko
3
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
4
The Waning Integrity of US Financial Markets
Todd Harrison
5
Tech News: Tesla Motors Inc's First Recall Is a Display of Public Relations Prowess
Josh Wolonick